Bart Malfait is a seasoned pharmaceutical leader with over 15 years of experience in global and local market strategy, marketing, sales, and market access. Currently serving as the Business Unit Director for Respiratory and Immunology at AstraZeneca, Bart has a track record of leading cross-functional teams and successfully launching innovative therapies. Previously, Bart held roles such as Market Access Director for Belgium and Luxembourg and Market Access Manager at The Janssen Pharmaceutical Companies of Johnson & Johnson, where they focused on bringing innovative medicines to patients. Bart completed a PhD in Biomedical Sciences at KU Leuven and has been recognized for their ability to cultivate trustworthy relationships with government bodies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices